相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Melanoma addiction to the long non-coding RNA SAMMSON
Eleonora Leucci et al.
NATURE (2016)
Linking Long Noncoding RNA Localization and Function
Ling-Ling Chen
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma
Maria Romina Girotti et al.
CANCER CELL (2015)
TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer
Jun Li et al.
CANCER RESEARCH (2015)
WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors
Jamie N. Anastas et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma
Amanda Lassen et al.
MOLECULAR CANCER (2014)
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Chong Sun et al.
NATURE (2014)
An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
Birgit Knoechel et al.
NATURE GENETICS (2014)
Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma
Yongjing Tian et al.
MELANOMA RESEARCH (2014)
Targeted Knockdown of IQGAP1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo
Xiao-Xia Wang et al.
PLOS ONE (2014)
Mutant NRASQ61 shares signaling similarities across various cancer types - potential implications for future therapies
Igor Vujic et al.
ONCOTARGET (2014)
Melanoma: Clinical Features and Genomic Insights
Elena B. Hawryluk et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
Paolo A. Ascierto et al.
LANCET ONCOLOGY (2013)
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
Cory M. Johannessen et al.
NATURE (2013)
Renewable RNAi
James A. Blau et al.
NATURE BIOTECHNOLOGY (2013)
IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase-driven tumors
Katherine L. Jameson et al.
NATURE MEDICINE (2013)
Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo
Christian Posch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
IQGAP1 is necessary for pulmonary vascular barrier protection in murine acute lung injury and pneumonia
M. Bhattacharya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)
Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs
Christopher T. Saunders et al.
BIOINFORMATICS (2012)
BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration
Ross J. Flockhart et al.
GENOME RESEARCH (2012)
The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression
Thomas Derrien et al.
GENOME RESEARCH (2012)
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The Melanoma-Upregulated Long Noncoding RNA SPRY4-IT1 Modulates Apoptosis and Invasion
Divya Khaitan et al.
CANCER RESEARCH (2011)
A Data Processing Pipeline for Mammalian Proteome Dynamics Studies Using Stable Isotope Metabolic Labeling
Shenheng Guan et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikos I. Poulikakos et al.
NATURE (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway
Mohammad Atefi et al.
PLOS ONE (2011)
IQGAP1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation by Akt activation
Feng Chen et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2010)
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M. Johannessen et al.
NATURE (2010)
Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation
Ramin Nazarian et al.
NATURE (2010)
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC
Nasim Ahmadiyeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
BRAF Gene Amplification Can Promote Acquired Resistance to MEK Inhibitors in Cancer Cells Harboring the BRAF V600E Mutation
Ryan B. Corcoran et al.
SCIENCE SIGNALING (2010)
IQGAP1 regulation and roles in cancer
Michael Johnson et al.
CELLULAR SIGNALLING (2009)
Accurate SHAPE-directed RNA structure determination
Katherine E. Deigan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family:: Identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF
Eric Pasmant et al.
CANCER RESEARCH (2007)
Genome-wide resources of endoribonuclease-prepared short interfering RNAs for specific loss-of-function studies
Ralf Kittler et al.
NATURE METHODS (2007)
Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases
KSM Smalley et al.
MOLECULAR CANCER THERAPEUTICS (2006)
IQGAP1 is a scaffold for mitogen-activated protein kinase signaling
M Roy et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
DEQOR: a web-based tool for the design and quality control of siRNAs
A Henschel et al.
NUCLEIC ACIDS RESEARCH (2004)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)